139 related articles for article (PubMed ID: 11295426)
41. Structural requirements for in vivo detection of cell death with 99mTc-annexin V.
Tait JF; Smith C; Blankenberg FG
J Nucl Med; 2005 May; 46(5):807-15. PubMed ID: 15872355
[TBL] [Abstract][Full Text] [Related]
42. A synthetic macromolecule for sentinel node detection: (99m)Tc-DTPA-mannosyl-dextran.
Vera DR; Wallace AM; Hoh CK; Mattrey RF
J Nucl Med; 2001 Jun; 42(6):951-9. PubMed ID: 11390562
[TBL] [Abstract][Full Text] [Related]
43. 99mTc-HYNIC-Gastrin Peptides: Assisted Coordination of 99mTc by Amino Acid Side Chains Results in Improved Performance Both In Vitro and In Vivo.
King R; Surfraz MB; Finucane C; Biagini SC; Blower PJ; Mather SJ
J Nucl Med; 2009 Apr; 50(4):591-8. PubMed ID: 19289435
[TBL] [Abstract][Full Text] [Related]
44. N,N-bis(2-mercaptoethyl)methylamine: a new coligand for Tc-99m labeling of hydrazinonicotinamide peptides.
Banerjee SR; Maresca KP; Stephenson KA; Valliant JF; Babich JW; Graham WA; Barzana M; Dong Q; Fischman AJ; Zubieta J
Bioconjug Chem; 2005; 16(4):885-902. PubMed ID: 16029030
[TBL] [Abstract][Full Text] [Related]
45. Preclinical evaluation of [99mTc/EDDA/tricine/HYNIC0, 1-Nal3, Thr8]-octreotide as a new analogue in the detection of somatostatin-receptor-positive tumors.
Gandomkar M; Najafi R; Shafiei M; Mazidi M; Ebrahimi SE
Nucl Med Biol; 2007 Aug; 34(6):651-7. PubMed ID: 17707805
[TBL] [Abstract][Full Text] [Related]
46. [
Kolay S; Kumar N; Guleria M; Das T
Bioorg Med Chem Lett; 2024 Jun; 105():129730. PubMed ID: 38583784
[TBL] [Abstract][Full Text] [Related]
47. Lys and Arg in UBI: a specific site for a stable Tc-99m complex?
Meléndez-Alafort L; Ramírez Fde M; Ferro-Flores G; Arteaga de Murphy C; Pedraza-López M; Hnatowich DJ
Nucl Med Biol; 2003 Aug; 30(6):605-15. PubMed ID: 12900286
[TBL] [Abstract][Full Text] [Related]
48. 99mTc-HYNIC-[Tyr3]-octreotide for imaging somatostatin-receptor-positive tumors: preclinical evaluation and comparison with 111In-octreotide.
Decristoforo C; Melendez-Alafort L; Sosabowski JK; Mather SJ
J Nucl Med; 2000 Jun; 41(6):1114-9. PubMed ID: 10855644
[TBL] [Abstract][Full Text] [Related]
49. [IgG radiolabelling with (99m)Tc by tricarbonyl method and its biodistribution in mice].
Chi XH; Huang BD; Wang B; Huang K; Li GP
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Dec; 30(12):2643-5. PubMed ID: 21177168
[TBL] [Abstract][Full Text] [Related]
50. Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors.
Laverman P; Béhé M; Oyen WJ; Willems PH; Corstens FH; Behr TM; Boerman OC
Bioconjug Chem; 2004; 15(3):561-8. PubMed ID: 15149184
[TBL] [Abstract][Full Text] [Related]
51. Application of high affinity binding concept to radiolabel avidin with Tc-99m labeled biotin and the effect of pI on biodistribution.
Jeong JM; Kinuya S; Paik CH; Saga T; Sood VK; Carrasquillo JA; Neumann RD; Reynolds JC
Nucl Med Biol; 1994 Oct; 21(7):935-40. PubMed ID: 9234347
[TBL] [Abstract][Full Text] [Related]
52. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D
Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305
[TBL] [Abstract][Full Text] [Related]
53. Clinical evaluation of antimicrobial peptide [(99m)Tc/Tricine/HYNIC(0)]ubiquicidin 29-41 as a human-specific infection imaging agent.
Gandomkar M; Najafi R; Shafiei M; Mazidi M; Goudarzi M; Mirfallah SH; Ebrahimi F; Heydarpor HR; Abdie N
Nucl Med Biol; 2009 Feb; 36(2):199-205. PubMed ID: 19217532
[TBL] [Abstract][Full Text] [Related]
54. (99m)Tc-labeled dimeric octreotide peptide: a radiotracer with high tumor uptake for single-photon emission computed tomography imaging of somatostatin receptor subtype 2-positive tumors.
Dong C; Zhao H; Yang S; Shi J; Huang J; Cui L; Zhong L; Jin X; Li F; Liu Z; Jia B; Wang F
Mol Pharm; 2013 Aug; 10(8):2925-33. PubMed ID: 23768172
[TBL] [Abstract][Full Text] [Related]
55. In-vivo biodistribution and safety of 99mTc-LLP2A-HYNIC in canine non-Hodgkin lymphoma.
Zwingenberger AL; Kent MS; Liu R; Kukis DL; Wisner ER; DeNardo SJ; Taylor SL; Chen X; Lam KS
PLoS One; 2012; 7(4):e34404. PubMed ID: 22545083
[TBL] [Abstract][Full Text] [Related]
56. Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide.
Bangard M; Béhé M; Guhlke S; Otte R; Bender H; Maecke HR; Biersack HJ
Eur J Nucl Med; 2000 Jun; 27(6):628-37. PubMed ID: 10901448
[TBL] [Abstract][Full Text] [Related]
57. A single-step kit formulation for the (99m)Tc-labeling of HYNIC-Duramycin.
Zhao M; Li Z
Nucl Med Biol; 2012 Oct; 39(7):1006-11. PubMed ID: 22858374
[TBL] [Abstract][Full Text] [Related]
58. Characterization of novel histidine-tagged Tat-peptide complexes dual-labeled with (99m)Tc-tricarbonyl and fluorescein for scintigraphy and fluorescence microscopy.
Bullok KE; Dyszlewski M; Prior JL; Pica CM; Sharma V; Piwnica-Worms D
Bioconjug Chem; 2002; 13(6):1226-37. PubMed ID: 12440857
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]